Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2018 Apr 4;8(4):e020904.
doi: 10.1136/bmjopen-2017-020904.

Relationship between islet autoantibody status and the clinical characteristics of children and adults with incident type 1 diabetes in a UK cohort

Vassiliki Bravis, Akaal Kaur  1 , Helen C Walkey  1 , Ian F Godsland  1 , Shivani Misra  1 , Polly J Bingley  2 , Alistair J K Williams  2 , David B Dunger  3 , Colin M Dayan  4 , Mark Peakman  5 , Nick S Oliver  1 , Desmond G Johnston  1 ; ADDRESS-2 Management Committee, Patient Advocate Group and Investigators
Collaborators, Affiliations
Observational Study

Relationship between islet autoantibody status and the clinical characteristics of children and adults with incident type 1 diabetes in a UK cohort

Vassiliki Bravis et al. BMJ Open. .

Abstract

Objectives: To describe the characteristics of children and adults with incident type 1 diabetes in contemporary, multiethnic UK, focusing on differences between the islet autoantibody negative and positive.

Design: Observational cohort study.

Setting: 146 mainly secondary care centres across England and Wales.

Participants: 3312 people aged ≥5 years were recruited within 6 months of a clinical diagnosis of type 1 diabetes via the National Institute for Health Research Clinical Research Network. 3021 were of white European ethnicity and 291 (9%) were non-white. There was a small male predominance (57%). Young people <17 years comprised 59%.

Main outcome measures: Autoantibody status and characteristics at presentation.

Results: The majority presented with classical osmotic symptoms, weight loss and fatigue. Ketoacidosis was common (42%), especially in adults, and irrespective of ethnicity. 35% were overweight or obese. Of the 1778 participants who donated a blood sample, 85% were positive for one or more autoantibodies against glutamate decarboxylase, islet antigen-2 and zinc transporter 8. Presenting symptoms were similar in the autoantibody-positive and autoantibody-negative participants, as was the frequency of ketoacidosis (43%vs40%, P=0.3). Autoantibody positivity was less common with increasing age (P=0.0001), in males compared with females (82%vs90%, P<0.0001) and in people of non-white compared with white ethnicity (73%vs86%, P<0.0001). Body mass index was higher in autoantibody-negative adults than autoantibody-positive adults (median, IQR 25.5, 23.1-29.2vs23.9, 21.4-26.7 kg/m2; P=0.0001). Autoantibody-negative participants were more likely to have a parent with diabetes (28%vs16%, P<0.0001) and less likely to have another autoimmune disease (4%vs8%, P=0.01).

Conclusions: Most people assigned a diagnosis of type 1 diabetes presented with classical clinical features and islet autoantibodies. Although indistinguishable at an individual level, autoantibody-negative participants as a group demonstrated features more typically associated with other diabetes subtypes.

Trial registration number: ISRCTN66496918; Pre-results.

Keywords: epidemiology; general diabetes; immunology; paediatric endocrinology.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Individual characteristics as predictors of diabetes presentation and autoantibody status. Univariate logistic regression ORs or linear regression coefficients (circles), 95% CIs (horizontal lines)# and statistical significances are shown. Red circles signify that a significant univariate relationship was sustained on multivariable analysis with all individual characteristics included as predictor variables (participants with complete data: n=2911–3312) and in the subgroup with antibodies measured (participants with complete data including antibody status: n=1610–1778). *Not significant in subgroup with antibodies measured on multivariable analysis. **Significant in subgroup with antibodies measured on multivariable analysis. †Not significant on multivariable analysis. ††Significant on multivariable analysis. #For ‘Age’, ORs or coefficients and 95% CIs were derived from standardised data. DM, diabetes mellitus.
Figure 2
Figure 2
The percentage of participants exhibiting islet autoantibodies (any and individual) in relation to age at diagnosis. GAD, glutamate decarboxylase; IA2, islet antigen-2; ZnT8, zinc transporter 8.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Todd JA. Etiology of type 1 diabetes. Immunity 2010;32:457–67. 10.1016/j.immuni.2010.04.001 - DOI - PubMed
    1. Palmer JP, Asplin CM, Clemons P, et al. . Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 1983;222:1337–9. 10.1126/science.6362005 - DOI - PubMed
    1. Bonifacio E, Genovese S, Braghi S, et al. . Islet autoantibody markers in IDDM: risk assessment strategies yielding high sensitivity. Diabetologia 1995;38:816–22. 10.1007/s001250050358 - DOI - PubMed
    1. Graham J, Hagopian WA, Kockum I, et al. . Genetic effects on age-dependent onset and islet cell autoantibody markers in type 1 diabetes. Diabetes 2002;51:1346–55. 10.2337/diabetes.51.5.1346 - DOI - PubMed
    1. Wenzlau JM, Juhl K, Yu L, et al. . The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc Natl Acad Sci U S A 2007;104:17040–5. 10.1073/pnas.0705894104 - DOI - PMC - PubMed

Publication types

Associated data